Trends and Sociodemographic Differences in Cancer Prevalence Among U.S. Adults

Overview

This study examines the trends and disparities in cancer prevalence among U.S. adults from 2019 to 2023, revealing stable overall rates but significant demographic disparities. The prevalence of breast and prostate cancers showed slight increases, while cervical cancer prevalence declined.

Background

Cancer is a leading cause of mortality in the United States, with significant implications for public health. Understanding trends in cancer prevalence and associated disparities is crucial for developing targeted interventions. This study utilizes data from the National Health Interview Survey to provide insights into the changing dynamics of cancer in the U.S.

Data Highlights

Key Findings

• The overall prevalence of any cancer remained stable from 2019 to 2023.
• White adults had the highest cancer prevalence at 11.7% in 2023, while Asians had the lowest at 3.5%.
• Breast cancer prevalence in females increased from 3.2% to 3.5% during the study period.
• Cervical cancer prevalence in females significantly declined from 1.1% to 0.9%.
• Prostate cancer prevalence in males rose slightly from 2.3% to 2.5%, with Black males showing the highest prevalence at 3.6%.
• Skin cancer prevalence in females increased from 3.0% to 3.3%, with the highest rates among White adults.

Clinical Implications

The findings highlight the need for targeted cancer control strategies to address disparities in cancer prevalence among different demographic groups. Understanding these trends can inform public health initiatives and resource allocation.

Conclusion

While the overall cancer prevalence has remained stable, significant disparities across demographic and socioeconomic factors persist.

Related Resources & Content

1. American Cancer Society, Cancer Facts & Figures 2026 -- Trends in Cancer Prevalence
2. HHS/HRSA, New Cervical Cancer Screening Guidelines -- Updated Guidance
3. CDC, National Health Interview Survey Data -- Interactive Summary Health Statistics
4. the asco post — Cancer Mortality Rates Continue to Decline, Incidence Rates in Women Rise, and Racial Disparities Persist
5. the asco post — Insights From Annual Report on Cancer Statistics
6. Frontiers in Gastroenterology — U.S.A. trends in intrahepatic and bile duct cancers from 1999–2023
7. The ASCO Post — Number of Cancer Survivors in the United States Reaches 18.6 Million and Projected to Exceed 22 Million by 2035
8. Cancer Mortality Rates Continue to Decline, Incidence Rates in Women Rise, and Racial Disparities Persist
9. Insights From Annual Report on Cancer Statistics
10. Cancer Facts & Figures 2026
11. WTAS: New Cervical Cancer Screening Guidelines | HHS.gov
12. https://wwwn.cdc.gov/NHISDataQueryTool/SHS_ADULT3YR/index.html?utm_source=openai
13. Technical Notes for Interactive Summary Health Statistics — 2019–2024: National Health Interview Survey
14. Final Recommendation Statement: Breast Cancer: Screening | United States Preventive Services Taskforce
15. Women’s Preventive Services Guidelines | HRSA
16. Screening for Cervical Cancer : Obstetrics & Gynecology
17. Should I Get Screened for Prostate Cancer? | Prostate Cancer | CDC
18. Updates to Early Detection of Prostate Cancer: AUA/SUO Guideline (2026) - PubMed
19. Recommendation: Skin Cancer: Screening | United States Preventive Services Taskforce
20. Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement | Breast Cancer | JAMA | JAMA Network
21. HRSA recommends offering self‐collection for cervical cancer screening - Lawrence - 2026 - Cancer - Wiley Online Library
22. Updates to Early Detection of Prostate Cancer: AUA/SUO Guideline (2026) - PubMed
23. Evidence Summary: Skin Cancer: Screening | United States Preventive Services Taskforce